Literature DB >> 15125481

Inflammatory status and endothelial function in asymptomatic and symptomatic peripheral arterial disease.

Antonio Silvestro1, Francesco Scopacasa, Aldo Ruocco, Gabriella Oliva, Vittorio Schiano, Carmela Zincarelli, Gregorio Brevetti.   

Abstract

Peripheral arterial disease (PAD) is a predictor of cardiovascular risk. However, it is unknown whether PAD severity influences inflammatory status and endothelial function, which play a major role in atherosclerosis. Accordingly, we measured brachial artery flow-mediated dilation (FMD), and plasma levels of several inflammatory markers in 15 control subjects, and 19 asymptomatic and 19 symptomatic PAD patients. Each symptomatic patient was matched to an asymptomatic patient for age, sex, risk factors, presence of cardiovascular disease, and pharmacological treatments. Asymptomatic patients had similar inflammatory profiles as controls, but lower median FMD (11.7% vs 8.5%, p < 0.01). Compared with asymptomatic patients, symptomatic patients had higher median C-reactive protein (1.5 mg/l vs 6.0 mg/l, p < 0.05) and interleukine-6 (1.5 pg/ml vs 3.5 pg/ml, p < 0.05), and lower FMD (8.5% vs 5.1%, p < 0.01). In the 38 PAD patients, the ankle/brachial pressure index correlated positively with FMD (p < 0.01), and negatively with C-reactive protein (p < 0.05), soluble intercellular adhesion molecule-1 (p < 0.05) and soluble vascular cell adhesion molecule-1 (p < 0.05). Thus, in PAD, endothelial function and inflammatory status are related to the severity of the circulatory impairment. This finding may contribute to the explanation of the increasingly poor prognosis with increased PAD severity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15125481     DOI: 10.1191/1358863x03vm503oa

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  16 in total

1.  Biomarkers of structural remodelling and endothelial dysfunction for prediction of cardiovascular events or death in patients with atrial fibrillation.

Authors:  Joachim R Ehrlich; Magdalena Kaluzny; Stefan Baumann; Ralf Lehmann; Stefan H Hohnloser
Journal:  Clin Res Cardiol       Date:  2011-07-03       Impact factor: 5.460

2.  Novel links among peroxiredoxins, endothelial dysfunction, and severity of atherosclerosis in type 2 diabetic patients with peripheral atherosclerotic disease.

Authors:  Eman El Eter; Abeer Al Masri; Shahid Habib; Hana Al Zamil; Ahmed Al Hersi; Fawaz Al Hussein; Mohamed Al Omran
Journal:  Cell Stress Chaperones       Date:  2013-06-26       Impact factor: 3.667

3.  Increased local cytokine production at culprit superficial femoral artery plaques.

Authors:  Cameron W Donaldson; David J Schneider; Daniel J Bertges; Julie E Adams; Nader Z Elgharib; Enkhtuyaa L Mueller; William Prabhu; Taka Ashikaga; Harold L Dauerman
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

Review 4.  Biomarkers of vascular disease in diabetes: the adipose-immune system cross talk.

Authors:  Federico Biscetti; Elisabetta Nardella; Andrea Leonardo Cecchini; Andrea Flex; Raffaele Landolfi
Journal:  Intern Emerg Med       Date:  2020-01-09       Impact factor: 3.397

5.  Walking disability in patients with peripheral artery disease is associated with arterial endothelial function.

Authors:  S Marlene Grenon; Karen Chong; Hugh Alley; Emily Nosova; Warren Gasper; Jade Hiramoto; W John Boscardin; Christopher D Owens
Journal:  J Vasc Surg       Date:  2014-01-11       Impact factor: 4.268

6.  Association of serum osteoprotegerin with ankle-brachial index and urine albumin: creatinine ratio in African-Americans and non-Hispanic whites.

Authors:  Zeenat Ali; Allison A Ellington; Thomas H Mosley; Iftikhar J Kullo
Journal:  Atherosclerosis       Date:  2009-04-05       Impact factor: 5.162

7.  Association of serum myeloperoxidase with the ankle-brachial index and peripheral arterial disease.

Authors:  Zeenat Ali; Paul Sarcia; Thomas H Mosley; Venkateswarlu Kondragunta; Iftikhar J Kullo
Journal:  Vasc Med       Date:  2009-08       Impact factor: 3.239

8.  Longitudinal Telomere Erosion in Lymphocyte Subsets of Patients with Atherosclerotic Peripheral Arterial Disease (PAD).

Authors:  Dirk de Beer; Jan Völzmann; Christoph Kalka; Gabriela M Baerlocher
Journal:  J Clin Diagn Res       Date:  2015-03-01

Review 9.  Modulation of vitamin D signaling is a potential therapeutic target to lower cardiovascular risk in chronic kidney disease.

Authors:  Peng Hu; Bo Hu; Jing Wang; Ling Lu; Yuan Han Qin
Journal:  Med Sci Monit       Date:  2011-06

10.  Systemic inflammation in peripheral arterial disease with or without coexistent chronic obstructive pulmonary disease: analysis of selected markers.

Authors:  Krzysztof Wozniak; Justyna Sleszycka; Aleksandra Safianowska; Wieslaw Wiechno; Joanna Domagala-Kulawik
Journal:  Arch Med Sci       Date:  2012-07-04       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.